OrbusNeich Medical Group Holdings Ltd. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Poor long term growth as Operating profit has grown by an annual rate -264.92% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Negative results in Jun 25

Risky -

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

HKD 3,660 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.57

Return on Equity

-999,999.00%

Price to Book

1.14

Revenue and Profits:

Net Sales:

47 Million

(Quarterly Results - Sep 2015)

Net Profit:

1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-16.22%

6 Months

3.91%

1 Year

-17.33%

2 Years

-39.9%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

OrbusNeich Medical Group Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

20.66%

EBIT Growth (5y)

-264.92%

EBIT to Interest (avg)

12.42

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.63

Sales to Capital Employed (avg)

0.10

Tax Ratio

47.21%

Dividend Payout Ratio

26.65%

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.21

EV to EBIT

-20.85

EV to EBITDA

-145.74

EV to Capital Employed

1.49

EV to Sales

11.68

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.16%

ROE (Latest)

-0.58%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'15 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2015 is 3.99% vs 21.24% in Sep 2014",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2015 is -85.00% vs 21.21% in Sep 2014",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'15",
        "Sep'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.90",
          "val2": "45.10",
          "chgp": "3.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.00",
          "val2": "14.30",
          "chgp": "-141.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.40",
          "val2": "3.00",
          "chgp": "146.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.20",
          "val2": "8.00",
          "chgp": "-85.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 12.43% vs 18.36% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 143.72% vs 519.71% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,204.60",
          "val2": "1,071.40",
          "chgp": "12.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "324.40",
          "val2": "258.40",
          "chgp": "25.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "11.50",
          "chgp": "-90.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.70",
          "val2": "-62.40",
          "chgp": "112.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "352.90",
          "val2": "144.80",
          "chgp": "143.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "241.90%",
          "val2": "212.80%",
          "chgp": "2.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'15 - YoY

Sep'15

Sep'14

Change(%)

Net Sales

46.90

45.10

3.99%

Operating Profit (PBDIT) excl Other Income

-6.00

14.30

-141.96%

Interest

7.40

3.00

146.67%

Exceptional Items

0.00

Consolidate Net Profit

1.20

8.00

-85.00%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2015 is 3.99% vs 21.24% in Sep 2014

Consolidated Net Profit

YoY Growth in quarter ended Sep 2015 is -85.00% vs 21.21% in Sep 2014

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

1,204.60

1,071.40

12.43%

Operating Profit (PBDIT) excl Other Income

324.40

258.40

25.54%

Interest

1.10

11.50

-90.43%

Exceptional Items

7.70

-62.40

112.34%

Consolidate Net Profit

352.90

144.80

143.72%

Operating Profit Margin (Excl OI)

241.90%

212.80%

2.91%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 12.43% vs 18.36% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 143.72% vs 519.71% in Dec 2022

All Annual Results

Company CV

About OrbusNeich Medical Group Holdings Ltd.

OrbusNeich Medical Group Holdings Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available